CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+7.92%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.38B
AUM Growth
+$7.38B
(-8.4%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-14.16%
Top 10 Holdings %
Top 10 Hldgs %
59.41%
Holding
95
New
3
Increased
19
Reduced
47
Closed
2
Top Buys
| 1 |
Intercontinental Exchange
ICE
|
$302M |
| 2 |
Royalty Pharma
RPRX
|
$6.54M |
| 3 |
Sarepta Therapeutics
SRPT
|
$4.1M |
| 4 |
Vaxcyte
PCVX
|
$3.25M |
| 5 |
Neurocrine Biosciences
NBIX
|
$2.51M |
Top Sells
| 1 |
Fiserv
FI
|
$298M |
| 2 |
Visa
V
|
$117M |
| 3 |
Microsoft
MSFT
|
$108M |
| 4 |
Amazon
AMZN
|
$98.9M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$80M |
Sector Composition
| 1 | Financials | 30.22% |
| 2 | Technology | 14.76% |
| 3 | Healthcare | 12.87% |
| 4 | Industrials | 12.28% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Elevance Health
ELV
$72.4B
| $35.4M | 0.48% |
91,054
+1,615
| +2% | +$628K |
|
27
Natera
NTRA
$23B
| $33.8M | 0.46% |
200,000
| – | – |
|
28
Edwards Lifesciences
EW
$47.7B
| $31M | 0.42% |
396,778
-1,540
| -0.4% | -$120K |
|
29
Insulet
PODD
$24.2B
| $29.8M | 0.4% |
94,908
-17,000
| -15% | -$5.34M |
|
30
Insmed
INSM
$30.3B
| $27.3M | 0.37% |
271,110
-50,000
| -16% | -$5.03M |
|
31
Tencent Music
TME
$38.5B
| $25.3M | 0.34% |
1,300,088
-181,518
| -12% | -$3.54M |
|
32
Mercado Libre
MELI
$120B
| $22.9M | 0.31% |
8,769
-74
| -0.8% | -$193K |
|
|
33
Royalty Pharma
RPRX
$15.8B
| $22.6M | 0.31% |
627,368
+181,530
| +41% | +$6.54M |
|
34
Medtronic
MDT
$118B
| $22.2M | 0.3% |
255,000
| – | – |
|
35
Service Corp International
SCI
$10.9B
| $21M | 0.29% |
258,413
+7,496
| +3% | +$610K |
|
36
Vertex Pharmaceuticals
VRTX
$102B
| $20.5M | 0.28% |
46,057
-8,000
| -15% | -$3.56M |
|
37
Penumbra
PEN
$10.5B
| $18.5M | 0.25% |
72,000
| – | – |
|
38
Zai Lab
ZLAB
$3.48B
| $17.8M | 0.24% |
510,000
+50,000
| +11% | +$1.75M |
|
39
Ionis Pharmaceuticals
IONS
$9.64B
| $17.8M | 0.24% |
450,000
+50,000
| +13% | +$1.98M |
|
40
Synopsys
SNPS
$110B
| $17.4M | 0.24% |
33,925
-378
| -1% | -$194K |
|
|
41
Neurocrine Biosciences
NBIX
$13.5B
| $17M | 0.23% |
135,000
+20,000
| +17% | +$2.51M |
|
42
Glaukos
GKOS
$5.42B
| $16.8M | 0.23% |
162,212
| – | – |
|
43
MakeMyTrip
MMYT
$9.52B
| $16M | 0.22% |
163,128
-37,836
| -19% | -$3.71M |
|
44
Align Technology
ALGN
$9.59B
| $15.8M | 0.21% |
83,428
| – | – |
|
45
KE Holdings
BEKE
$21.8B
| $14.9M | 0.2% |
840,816
-117,032
| -12% | -$2.08M |
|
46
PTC
PTC
$25.4B
| $14.7M | 0.2% |
85,487
-952
| -1% | -$164K |
|
47
ResMed
RMD
$39.4B
| $14.7M | 0.2% |
56,924
-632
| -1% | -$163K |
|
48
MSCI
MSCI
$42.7B
| $14.2M | 0.19% |
24,636
-272
| -1% | -$157K |
|
49
Tyler Technologies
TYL
$24B
| $14.1M | 0.19% |
23,718
-264
| -1% | -$157K |
|
50
Privia Health
PRVA
$2.84B
| $14M | 0.19% |
610,000
| – | – |
|